Bioheart converts debt

As part its restructuring to improve its chances of securing additional financing, Bioheart (BHRT -6.7%) settles a debt of $1,508,219.19 by issuing 37,705,478 shares of common stock. The transaction represents a 7.6% dilution for current shareholders.

The current holders of the company's Series A Convertible Preferred Stock have agreed to exchange their shares for shares of common stock contingent upon the company securing financing.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs